vs
Side-by-side financial comparison of BYLINE BANCORP, INC. (BY) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.
BYLINE BANCORP, INC. is the larger business by last-quarter revenue ($112.4M vs $76.2M, roughly 1.5× VIEMED HEALTHCARE, INC.). BYLINE BANCORP, INC. runs the higher net margin — 33.4% vs 7.4%, a 26.0% gap on every dollar of revenue. On growth, VIEMED HEALTHCARE, INC. posted the faster year-over-year revenue change (25.5% vs 9.0%). Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs 6.4%).
Byline Bank is a bank headquartered in Chicago, Illinois, United States. It is the primary subsidiary of Byline Bancorp, Inc., a bank holding company, and the 4th largest SBA 7(a) lender.
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
BY vs VMD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $112.4M | $76.2M |
| Net Profit | $37.6M | $5.6M |
| Gross Margin | — | 57.9% |
| Operating Margin | — | 11.0% |
| Net Margin | 33.4% | 7.4% |
| Revenue YoY | 9.0% | 25.5% |
| Net Profit YoY | 33.0% | 30.7% |
| EPS (diluted) | $0.83 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $112.4M | — | ||
| Q4 25 | $117.0M | $76.2M | ||
| Q3 25 | $115.7M | $71.9M | ||
| Q2 25 | $110.5M | $63.1M | ||
| Q1 25 | $103.1M | $59.1M | ||
| Q4 24 | $104.7M | $60.7M | ||
| Q3 24 | $101.8M | $58.0M | ||
| Q2 24 | $99.4M | $55.0M |
| Q1 26 | $37.6M | — | ||
| Q4 25 | $34.5M | $5.6M | ||
| Q3 25 | $37.2M | $3.5M | ||
| Q2 25 | $30.1M | $3.2M | ||
| Q1 25 | $28.2M | $2.6M | ||
| Q4 24 | $30.3M | $4.3M | ||
| Q3 24 | $30.3M | $3.9M | ||
| Q2 24 | $29.7M | $1.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | 57.9% | ||
| Q3 25 | — | 57.5% | ||
| Q2 25 | — | 58.3% | ||
| Q1 25 | — | 56.3% | ||
| Q4 24 | — | 59.5% | ||
| Q3 24 | — | 59.3% | ||
| Q2 24 | — | 59.8% |
| Q1 26 | — | — | ||
| Q4 25 | 40.1% | 11.0% | ||
| Q3 25 | 43.1% | 7.8% | ||
| Q2 25 | 35.2% | 8.1% | ||
| Q1 25 | 36.4% | 6.5% | ||
| Q4 24 | 38.6% | 10.6% | ||
| Q3 24 | 39.3% | 9.7% | ||
| Q2 24 | 40.4% | 6.6% |
| Q1 26 | 33.4% | — | ||
| Q4 25 | 34.1% | 7.4% | ||
| Q3 25 | 32.1% | 4.9% | ||
| Q2 25 | 27.2% | 5.0% | ||
| Q1 25 | 27.4% | 4.4% | ||
| Q4 24 | 34.3% | 7.1% | ||
| Q3 24 | 29.8% | 6.7% | ||
| Q2 24 | 29.9% | 2.7% |
| Q1 26 | $0.83 | — | ||
| Q4 25 | $0.77 | $0.14 | ||
| Q3 25 | $0.82 | $0.09 | ||
| Q2 25 | $0.66 | $0.08 | ||
| Q1 25 | $0.64 | $0.06 | ||
| Q4 24 | $0.68 | $0.10 | ||
| Q3 24 | $0.69 | $0.10 | ||
| Q2 24 | $0.68 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $198.4M | $13.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.3B | $141.5M |
| Total Assets | $9.9B | $199.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $198.4M | — | ||
| Q4 25 | $149.1M | $13.5M | ||
| Q3 25 | $259.0M | $11.1M | ||
| Q2 25 | $218.3M | $20.0M | ||
| Q1 25 | $421.3M | $10.2M | ||
| Q4 24 | $563.1M | $17.5M | ||
| Q3 24 | $452.6M | $11.3M | ||
| Q2 24 | $730.5M | $8.8M |
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $141.5M | ||
| Q3 25 | $1.2B | $133.6M | ||
| Q2 25 | $1.2B | $139.7M | ||
| Q1 25 | $1.1B | $134.8M | ||
| Q4 24 | $1.1B | $131.4M | ||
| Q3 24 | $1.1B | $125.0M | ||
| Q2 24 | $1.0B | $119.4M |
| Q1 26 | $9.9B | — | ||
| Q4 25 | $9.7B | $199.2M | ||
| Q3 25 | $9.8B | $202.4M | ||
| Q2 25 | $9.7B | $184.6M | ||
| Q1 25 | $9.6B | $178.1M | ||
| Q4 24 | $9.5B | $177.1M | ||
| Q3 24 | $9.4B | $169.5M | ||
| Q2 24 | $9.6B | $163.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $18.4M |
| Free Cash FlowOCF − Capex | — | $9.7M |
| FCF MarginFCF / Revenue | — | 12.7% |
| Capex IntensityCapex / Revenue | — | 11.5% |
| Cash ConversionOCF / Net Profit | — | 3.27× |
| TTM Free Cash FlowTrailing 4 quarters | — | $11.9M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $140.3M | $18.4M | ||
| Q3 25 | $38.3M | $18.4M | ||
| Q2 25 | $16.3M | $12.3M | ||
| Q1 25 | $27.1M | $2.9M | ||
| Q4 24 | $175.2M | $15.0M | ||
| Q3 24 | $19.8M | $12.7M | ||
| Q2 24 | $40.1M | $10.2M |
| Q1 26 | — | — | ||
| Q4 25 | $136.3M | $9.7M | ||
| Q3 25 | $38.0M | $10.7M | ||
| Q2 25 | $15.2M | $4.1M | ||
| Q1 25 | $25.0M | $-12.6M | ||
| Q4 24 | $171.2M | $3.2M | ||
| Q3 24 | $19.1M | $1.7M | ||
| Q2 24 | $39.4M | $1.2M |
| Q1 26 | — | — | ||
| Q4 25 | 116.5% | 12.7% | ||
| Q3 25 | 32.8% | 14.9% | ||
| Q2 25 | 13.7% | 6.5% | ||
| Q1 25 | 24.3% | -21.4% | ||
| Q4 24 | 163.5% | 5.2% | ||
| Q3 24 | 18.8% | 3.0% | ||
| Q2 24 | 39.7% | 2.3% |
| Q1 26 | — | — | ||
| Q4 25 | 3.4% | 11.5% | ||
| Q3 25 | 0.3% | 10.6% | ||
| Q2 25 | 1.0% | 12.9% | ||
| Q1 25 | 2.0% | 26.2% | ||
| Q4 24 | 3.8% | 19.5% | ||
| Q3 24 | 0.6% | 19.0% | ||
| Q2 24 | 0.7% | 16.3% |
| Q1 26 | — | — | ||
| Q4 25 | 4.06× | 3.27× | ||
| Q3 25 | 1.03× | 5.23× | ||
| Q2 25 | 0.54× | 3.88× | ||
| Q1 25 | 0.96× | 1.09× | ||
| Q4 24 | 5.78× | 3.47× | ||
| Q3 24 | 0.65× | 3.29× | ||
| Q2 24 | 1.35× | 6.94× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
